Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
D., Zhang, C
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
A national speaker and author, Derricks unique style is to bridge the regulatory requirements with the practical realities of day-to-day operations
11 CDC (Subcut Injection PDF)Technique diagram and site guidance for subcutaneous injections
US$ 23.23
US$ 25.98
US$ 21.63
US$ 24.85
US$ 24.89
US$ 24.06
US$ 23.35